Eisai's regional Gary Hendler spoke to PharmaDispatch during a recent trip to Australia, touching on the company's approach to innovation, how governments are attracting industry investment, Eisai's growth in Australia and even its attitude to medicine pricing. …
Eisai's Gary Hendler on Australia, investment and a pragmatic approach to pricing
January 22, 2019 Latest NewsBioPharmaDispatch Executive
Latest Video
New Stories
-
This exchange on the HTA Review was about as underwhelming as it sounds
October 9, 2025 - - Latest News -
AusBiotech unveils international conference program for Australia’s biggest week in biotech
October 9, 2025 - - Australian Biotech -
Life sciences industry calls for stronger national strategy to support trials and innovation
October 9, 2025 - - Latest News -
Officials outline ongoing measures to address ADHD medicine shortages
October 9, 2025 - - Latest News -
Pharmaceutical spending to rise by around $10 billion, but still lose ground to other programs
October 9, 2025 - - Latest News -
Australian company reports positive outcome from collaboration
October 8, 2025 - - Australian Biotech -
CUREator opens $33 million funding round with CSL and AbbVie partnership
October 8, 2025 - - Latest News